Paradromics Receives FDA Approval to Expand BCI Access to Personal Computing Devices in Clinical Study
Paradromics has received FDA approval to expand the types of computing devices that may be used with its investigational brain-computer interface (BCI) system in the Connect-One clinical study, enabling compatibility with personal laptops, tablets, and phones through its Convey user interface.
詳細情報